# Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

> clinical trial · VERIFIED · 2026-07-30

Status: RECRUITING · Sponsor: Allogene Therapeutics · Condition: Large B-cell Lymphoma

- Company: Allogene Therapeutics
- Sector: Large B-cell Lymphoma
- Primary source: https://clinicaltrials.gov/study/NCT06500273

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.